Acute Myeloid Leukemia
The diagnosis and management of hematologic malignancies during pregnancy
In this episode of the VJHemOnc podcast, Daan Dierickx, MD, PhD, KU Leuven and University Hospitals Leuven, Leuven, Belgium, shares…
Date: 16th July 2026
Precision medicine in AML: from targeted therapy to transplantation
This podcast explores the evolving role of precision medicine in acute myeloid leukemia (AML), highlighting advances in molecular profiling, targeted…
Date: 22nd June 2026
MRD in ALL and AML: from prognostic marker to clinical endpoint
This VJHemOnc podcast explores the evolving role of measurable residual disease (MRD) in acute myeloid leukemia (AML) and acute lymphoblastic…
Date: 20th March 2026
Top ASH 2025 updates in AML: redefining frontline therapy, menin inhibition, venetoclax-based triplets, & emerging immunotherapies
This VJHemOnc podcast highlights key acute myeloid leukemia (AML) updates from ASH 2025. Amir Fathi, MD, MPH, Massachusetts General Hospital,…
Date: 30th January 2026
Accelerated- and blast-phase MPNs: diagnosis, management, and current challenges
This episode of the VJHemOnc podcast focuses on accelerated and blast-phase myeloproliferative neoplasms (MPN-AP/BP), offering insights into their diagnosis and…
Date: 20th November 2025
The value and utility of MRD in the management of adults with newly-diagnosed AML
This podcast features experts Mark Levis, MD, PhD, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, Sanam Loghavi, MD, The University…
Date: 14th November 2025
Reviewing recent guideline updates on the risk stratification and treatment of AML
In this episode of the VJHemOnc Podcast, we are joined by Shai Shimony, MD, Dana-Farber Cancer Institute, Boston, MA, and…
Date: 10th October 2025
FLT3-ITD+ AML: recent trial updates, novel approaches, and MRD
This podcast focuses on FLT3-ITD-positive acute myeloid leukemia (FLT3-ITD+ AML), featuring experts Amir Fathi, MD, MPH, Massachusetts General Hospital, Boston,…
Date: 15th August 2025
Treating elderly or unfit patients with AML: current approach and future directions
This episode of the VJHemOnc podcast focuses on the treatment of elderly or unfit patients with acute myeloid leukemia (AML)….
Date: 4th July 2025
CHIP & CCUS: advances in understanding and should we treat these precursor conditions?
In this episode of the VJHemOnc podcast, we explore clonal hematopoiesis of indeterminate potential (CHIP) and clonal cytopenia of unknown…
Date: 20th June 2025
Post-ASH AML highlights: novel approaches to frontline therapy, advances with menin inhibitors, & managing FLT3-ITD+ AML
In this podcast, we bring you exclusive updates in acute myeloid leukemia (AML) from the 66th American Society of Hematology…
Date: 31st January 2025
The treatment landscape and challenges in rare diseases: BPDCN, CMML, MPN-AP/BP, and VEXAS
This podcast features a discussion from the 6th International Workshop on Acute Leukemias (iwAL) 2024, which took place in Phoenix,…
Date: 6th November 2024
